IL-4 dysregulates microRNAs involved in inflammation, angiogenesis and apoptosis in epidermal keratinocytes

Lei Bao1, Cecilia Chau2, Jeremy Bao1

  • 1Department of Dermatology, University of Illinois, 808 S Wood St., Chicago, Illinois 60612, USA.

Microbiology and Immunology
|September 22, 2018
PubMed

Insights

Interleukin-4 (IL-4) dysregulates microRNAs in atopic dermatitis (AD), impacting inflammation and cell death pathways. These microRNAs offer potential therapeutic targets for AD treatment.

Area of Science:

  • Immunology
  • Molecular Biology
  • Dermatology

Background:

  • Interleukin-4 (IL-4) is a key cytokine in atopic dermatitis (AD) pathogenesis.
  • IL-4 influences gene expression at the transcriptional level in AD.

Purpose of the Study:

  • To investigate the role of IL-4 in microRNA (miRNA) dysregulation in AD.
  • To identify specific miRNAs affected by IL-4 in AD pathogenesis.

Main Methods:

  • Utilized a microRNA array technique.
  • Employed IL-4 transgenic mouse models.

Main Results:

  • IL-4 dysregulated 27 common miRNAs, with 26 upregulated and 1 downregulated.
  • Significantly upregulated miRNAs include miR-101-5p, miR-122-5p, miR-142-3p, miR-204-5p, miR-335-3p, miR-376a-3p, miR-378a-5p, miR-639, and miR-9-5p.
  • Downregulated miRNA, miR-147a, attenuates TLR-induced inflammatory responses.

Conclusions:

  • Dysregulated miRNAs identified in this study may post-transcriptionally regulate key genes in AD.
  • These findings suggest potential miRNA-based therapeutic strategies for atopic dermatitis.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.0K
Inflammation01:38

Inflammation

Overview
62.1K
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
15.1K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.8K
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
1.5K